PRESS RELEASE published on 01/07/2026 at 08:05, 4 months 7 days ago Rockwell Automation Announces Latest Season of ROKStudios Video Series Showcasing the Future of Industrial Operations and Sustainable Transformation Rockwell Automation announces latest season of ROKStudios video series, highlighting digitalization, sustainability, and smart automation in industrial operations Sustainability Digitalization Rockwell Automation Industrial Operations ROKStudios
PRESS RELEASE published on 01/07/2026 at 08:00, 4 months 7 days ago Transaction in Own Shares Molten Ventures Plc (LSE: GROW) reports transaction in own shares, purchasing 50,000 Ordinary Shares at 515.0325p average price per share on 6 Jan 2026 Share Repurchase Molten Ventures Plc Own Shares GROW Transaction
PRESS RELEASE published on 01/07/2026 at 08:00, 4 months 7 days ago Aquis Stock Exchange: Withdrawal from trading Aquis Stock Exchange announces the withdrawal of Amazing AI Plc's ordinary shares (symbol: AAI, ISIN: GB00BPQC9525) from trading on the Aquis Growth Market Trading Aquis Stock Exchange Aquis Growth Market Withdrawal Amazing AI PLC
PRESS RELEASE published on 01/07/2026 at 08:00, 4 months 7 days ago Pentixapharm Receives FDA Feedback for Phase 3 Diagnostic Study in Hypertension Pentixapharm receives FDA feedback for Phase 3 diagnostic study in hypertension, providing clarity on study design and approval pathway. Formal guidance enhances IND submission preparations FDA Feedback Diagnostic Hypertension Phase 3 Study Pentixapharm
PRESS RELEASE published on 01/07/2026 at 08:00, 4 months 7 days ago Grande Portage Receives US Forest Service Special Use Permit for Environmental Infrastructure at the New Amalga Gold Project Grande Portage Resources announces US Forest Service Special Use Permit for New Amalga Gold Project; focuses on low-footprint underground mining operation. NI43-101 Mineral Resource Estimate updated NI43-101 Grande Portage Resources Underground Mining New Amalga Gold Project US Forest Service
PRESS RELEASE published on 01/07/2026 at 08:00, 4 months 7 days ago CBI continues to implement its ACE strategy during December 2025 CBI continues to implement its ACE strategy during December 2025, maintaining stable mining returns in Bitcoins and exceeding 13% per annum in USD. The company aims to expand its server fleet and remains focused on holding Bitcoins for potential market rebound Bitcoin CBI ACE Strategy Mining Returns Server Fleet
PRESS RELEASE published on 01/07/2026 at 08:00, 4 months 7 days ago THX Pharma Announces the Appointment of Julien Veys as Deputy Chief Executive Officer THX Pharma appoints Julien Veys as Deputy CEO to drive new strategy focusing on regulatory approval and commercialization of medicines for rare neurological diseases Regulatory Approval Deputy CEO Neurological Diseases THX Pharma Julien Veys
PRESS RELEASE published on 01/07/2026 at 07:30, 4 months 7 days ago Nordex obtains orders for 414 MW in France, Belgium and Portugal Nordex secures orders for 414 MW in France, Belgium, and Portugal for wind energy projects with multiple turbine models and long-term service agreements, strengthening its position in French-speaking Europe Orders Portugal France Wind Energy Nordex
PRESS RELEASE published on 01/07/2026 at 07:30, 4 months 7 days ago DriX H-9 drone: Exail announces two new orders, one of which integrates aerial anti-drone capabilities Exail announces signing of two contracts for its DriX H-9 surface drone, accelerating adoption of autonomous solutions in maritime defense and security. CUAS capability for countering air threats and SHOM order for seabed mapping highlight system's versatility and operational relevance Exail Technologies Autonomous Solutions DriX H-9 Maritime Defense Surface Drone
PRESS RELEASE published on 01/07/2026 at 07:00, 4 months 7 days ago Newron Pharmaceuticals S.p.A.: EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan Newron Pharmaceuticals S.p.A. announces Phase III Clinical Trial initiation with Evenamide, a novel Schizophrenia treatment in Japan, led by EA Pharma, a subsidiary of Eisai Schizophrenia Newron Pharmaceuticals Evenamide Phase III EA Pharma
Published on 05/14/2026 at 15:10, 1 hour 13 minutes ago Banyan Provides Summary of 2025 Diamond Drill Program for the Flagship AurMac Project, Yukon, Canada
Published on 05/14/2026 at 15:00, 1 hour 23 minutes ago Karbon-X Explores Clean Cooking and Fish Smoking Climate Initiative Concept in Senegal
Published on 05/14/2026 at 15:00, 1 hour 23 minutes ago ACCESS Newswire Celebrates PRSSA Bateman Competition Success and the Next Generation of Communications Leaders
Published on 05/14/2026 at 14:50, 1 hour 33 minutes ago Germany's BGR Assesses NextSource Materials' Molo Graphite Mine as Part of Federal Critical Minerals Study
Published on 05/14/2026 at 14:30, 1 hour 53 minutes ago Boron One Holdings Inc. Completes Its Jarandol Basin Exploration Program for 2026
Published on 05/14/2026 at 16:15, 7 minutes ago Fibank successfully closed a record-breaking international placement for a Bulgarian bank, raising a total of EUR 310 million across two bond issues
Published on 05/14/2026 at 14:55, 1 hour 27 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 05/14/2026 at 14:54, 1 hour 28 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 05/14/2026 at 14:53, 1 hour 29 minutes ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 05/13/2026 at 17:45, 22 hours 38 minutes ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
Published on 05/13/2026 at 17:45, 22 hours 38 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026
Published on 05/13/2026 at 17:40, 22 hours 43 minutes ago Report on share repurchases from 6 to 12 May 2026
Published on 05/13/2026 at 16:00, 1 day ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES